Prostaglandin-induced abortion: assessment of operative complications and early morbidity.
A total of 626 patients undergoing a prostaglandin-induced abortion, the majority in the second trimester, have been analysed for complications occurring during inpatient treatment. Of the last 155 consecutive patients 143 were critically assessed six to eight weeks after abortion for morbidity occurring during their early recovery period.Blood loss of 250 ml or more occurred in 68 patients, pyrexia in 34, pelvic infection in three, and readmission in 14 of the 626 patients studied, and a transfusion was required in eight.Bleeding after abortion stopped within six weeks in all 143 of the 155 consecutive patients assessed but three required readmission for uterine curettage. Menstruation was re-established within six weeks of abortion in 106 patients.The incidence of operative morbidity was similar to that reported for first trimester abortion and better than that in most reported series of second trimester abortions.
D000028:Abortion, Induced / Q000009:adverse effects*; D000650:Amnion; D001803:Blood Transfusion; D003267:Contraception; D003475:Curettage; D005260:Female; D005334:Fever / Q000209:etiology; D005500:Follow-Up Studies; D005865:Gestational Age; D006801:Humans; D007022:Hypotension / Q000209:etiology; D007267:Injections; D007902:Length of Stay; D008598:Menstruation; D008722:Methods; D011183:Postoperative Complications; D011247:Pregnancy; D011453:Prostaglandins / Q000627:therapeutic use*; D014592:Uterine Hemorrhage / Q000209:etiology; D014839:Vomiting / Q000139:chemically induced
D011453:Prostaglandins